Herzog TJ - Search Results

1

Topotecan in squamous cell carcinoma of the cervix: A Phase II study of the Gynecologic Oncology Group.

Bookman MA, Blessing JA, Hanjani P, Herzog TJ, Andersen WA. Bookman MA, et al. Among authors: herzog tj. Gynecol Oncol. 2000 Jun;77(3):446-9. doi: 10.1006/gyno.2000.5807. Gynecol Oncol. 2000. PMID: 10831357 Clinical Trial.

2

Effects of radiation on TNF alpha-mediated cytolysis of cell lines derived from cervical carcinomas.

Herzog TJ, Nelson PK, Mutch DG, Wright WD, Kao MS, Collins JL. Herzog TJ, et al. Gynecol Oncol. 1992 Nov;47(2):196-202. doi: 10.1016/0090-8258(92)90106-s. Gynecol Oncol. 1992. PMID: 1468697

3

Correlates of length of stay in gynecologic oncology patients undergoing inpatient surgery.

Massad LS, Vogler G, Herzog TJ, Mutch DG. Massad LS, et al. Among authors: herzog tj. Gynecol Oncol. 1993 Nov;51(2):214-8. doi: 10.1006/gyno.1993.1275. Gynecol Oncol. 1993. PMID: 8276297

4

Topotecan in platinum- and paclitaxel-resistant ovarian cancer.

Swisher EM, Mutch DG, Rader JS, Elbendary A, Herzog TJ. Swisher EM, et al. Among authors: herzog tj. Gynecol Oncol. 1997 Sep;66(3):480-6. doi: 10.1006/gyno.1997.4787. Gynecol Oncol. 1997. PMID: 9299264 Clinical Trial.

5

Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery.

Grigsby PW, Perez CA, Chao KS, Elbendary A, Herzog TJ, Rader JS, Mutch DG. Grigsby PW, et al. Among authors: herzog tj. Int J Radiat Oncol Biol Phys. 1999 Oct 1;45(3):645-51. doi: 10.1016/s0360-3016(99)00217-5. Int J Radiat Oncol Biol Phys. 1999. PMID: 10524418

6

Lack of efficacy of 24-h infusional topotecan in platinum-refractory ovarian cancer: A Gynecologic Oncology Group trial.

Markman M, Blessing JA, DeGeest K, Morgan M, Look KY, Herzog TJ, Rose PG. Markman M, et al. Among authors: herzog tj. Gynecol Oncol. 1999 Dec;75(3):444-6. doi: 10.1006/gyno.1999.5640. Gynecol Oncol. 1999. PMID: 10600304 Clinical Trial.

7

Factors predicting subcutaneous implanted central venous port function: the relationship between catheter tip location and port failure in patients with gynecologic malignancies.

Cohn DE, Mutch DG, Rader JS, Farrell M, Awantang R, Herzog TJ. Cohn DE, et al. Among authors: herzog tj. Gynecol Oncol. 2001 Dec;83(3):533-6. doi: 10.1006/gyno.2001.6433. Gynecol Oncol. 2001. PMID: 11733967

8

Clinical experience with topotecan in relapsed ovarian cancer.

Herzog TJ. Herzog TJ. Gynecol Oncol. 2003 Sep;90(3 Pt 2):S3-7. doi: 10.1016/s0090-8258(03)00467-0. Gynecol Oncol. 2003. PMID: 13129489 Review.

9

New approaches for the management of cervical cancer.

Herzog TJ. Herzog TJ. Gynecol Oncol. 2003 Sep;90(3 Pt 2):S22-7. doi: 10.1016/s0090-8258(03)00466-9. Gynecol Oncol. 2003. PMID: 13129492 Review.

10

Workshop: options for therapy in ovarian cancer.

Herzog TJ, Holloway RW, Stuart GC. Herzog TJ, et al. Gynecol Oncol. 2003 Sep;90(3 Pt 2):S45-50. doi: 10.1016/s0090-8258(03)00473-6. Gynecol Oncol. 2003. PMID: 13129496 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

404 results

Search Page

Filters